(Q44733418)

English

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients (English)

1 reference

Europe PubMed Central

5 December 2017

1 reference

based on heuristic

inferred from title

author name string

Del Toro G

1

1 reference

Europe PubMed Central

5 December 2017

Satwani P

2

1 reference

Europe PubMed Central

5 December 2017

Harrison L

3

1 reference

Europe PubMed Central

5 December 2017

Cheung YK

4

1 reference

Europe PubMed Central

5 December 2017

Brigid Bradley M

5

1 reference

Europe PubMed Central

5 December 2017

George D

6

1 reference

Europe PubMed Central

5 December 2017

Yamashiro DJ

7

1 reference

Europe PubMed Central

5 December 2017

Garvin J

8

1 reference

Europe PubMed Central

5 December 2017

Skerrett D

9

1 reference

Europe PubMed Central

5 December 2017

Bessmertny O

10

1 reference

Europe PubMed Central

5 December 2017

Wolownik K

11

1 reference

Europe PubMed Central

5 December 2017

Wischhover C

12

1 reference

Europe PubMed Central

5 December 2017

van de Ven C

13

1 reference

Europe PubMed Central

5 December 2017

Cairo MS

14

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

5 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

5 December 2017

33

1 reference

Europe PubMed Central

5 December 2017

6

1 reference

Europe PubMed Central

5 December 2017

613-622

1 reference

Europe PubMed Central

5 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704399

0 references

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Ovarian function following marrow transplantation for aplastic anemia or leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Solid cancers after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

21 January 2018

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704399

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704399

1 reference

Europe PubMed Central

5 December 2017

release_klmyiver7nhszjao6eubqb6bsy

1 reference

https://api.fatcat.wiki/v0/release/klmyiver7nhszjao6eubqb6bsy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44733418&oldid=2035570517"